Global CAR T-Cell Immunotherapy Market Research Report 2022

Global CAR T-Cell Immunotherapy Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hematologic Malignancies
1.3.3 Solid Malignancies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Immunotherapy Market Perspective (2017-2028)
2.2 CAR T-Cell Immunotherapy Growth Trends by Region
2.2.1 CAR T-Cell Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2017-2022)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028)
2.3 CAR T-Cell Immunotherapy Market Dynamics
2.3.1 CAR T-Cell Immunotherapy Industry Trends
2.3.2 CAR T-Cell Immunotherapy Market Drivers
2.3.3 CAR T-Cell Immunotherapy Market Challenges
2.3.4 CAR T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2017-2022)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2021
3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Immunotherapy Breakdown Data by Type
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2017-2022)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028)
5 CAR T-Cell Immunotherapy Breakdown Data by Application
5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2017-2022)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America CAR T-Cell Immunotherapy Market Size (2017-2028)
6.2 North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
6.3 North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe CAR T-Cell Immunotherapy Market Size (2017-2028)
7.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2017-2028)
8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America CAR T-Cell Immunotherapy Market Size (2017-2028)
9.2 Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
9.3 Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2017-2028)
10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022)
10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.1.5 AbbVie Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.2.5 Celgene Recent Development
11.3 Kite Pharma
11.3.1 Kite Pharma Company Detail
11.3.2 Kite Pharma Business Overview
11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.3.5 Kite Pharma Recent Development
11.4 Oxford BioMedica
11.4.1 Oxford BioMedica Company Detail
11.4.2 Oxford BioMedica Business Overview
11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.4.5 Oxford BioMedica Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.5.5 Novartis Recent Development
11.6 Gilead
11.6.1 Gilead Company Detail
11.6.2 Gilead Business Overview
11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.6.5 Gilead Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.7.5 Pfizer Recent Development
11.8 Cellectis
11.8.1 Cellectis Company Detail
11.8.2 Cellectis Business Overview
11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.8.5 Cellectis Recent Development
11.9 Bellicum
11.9.1 Bellicum Company Detail
11.9.2 Bellicum Business Overview
11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.9.5 Bellicum Recent Development
11.10 Mustang Bio
11.10.1 Mustang Bio Company Detail
11.10.2 Mustang Bio Business Overview
11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.10.5 Mustang Bio Recent Development
11.11 CARsgen Therapeutics
11.11.1 CARsgen Therapeutics Company Detail
11.11.2 CARsgen Therapeutics Business Overview
11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.11.5 CARsgen Therapeutics Recent Development
11.12 Xyphos
11.12.1 Xyphos Company Detail
11.12.2 Xyphos Business Overview
11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.12.5 Xyphos Recent Development
11.13 Minerva Biotechnologies
11.13.1 Minerva Biotechnologies Company Detail
11.13.2 Minerva Biotechnologies Business Overview
11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.13.5 Minerva Biotechnologies Recent Development
11.14 Adaptimmune
11.14.1 Adaptimmune Company Detail
11.14.2 Adaptimmune Business Overview
11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.14.5 Adaptimmune Recent Development
11.15 Ziopharm Oncology
11.15.1 Ziopharm Oncology Company Detail
11.15.2 Ziopharm Oncology Business Overview
11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.15.5 Ziopharm Oncology Recent Development
11.16 Aurora Biopharma
11.16.1 Aurora Biopharma Company Detail
11.16.2 Aurora Biopharma Business Overview
11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.16.5 Aurora Biopharma Recent Development
11.17 Creative Biolabs
11.17.1 Creative Biolabs Company Detail
11.17.2 Creative Biolabs Business Overview
11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
11.17.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2017-2022)
Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2023-2028)
Table 10. CAR T-Cell Immunotherapy Market Trends
Table 11. CAR T-Cell Immunotherapy Market Drivers
Table 12. CAR T-Cell Immunotherapy Market Challenges
Table 13. CAR T-Cell Immunotherapy Market Restraints
Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Players (2017-2022)
Table 16. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021)
Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2017-2022)
Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2023-2028)
Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2017-2022)
Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2023-2028)
Table 31. North America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. AbbVie Company Detail
Table 42. AbbVie Business Overview
Table 43. AbbVie CAR T-Cell Immunotherapy Product
Table 44. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 45. AbbVie Recent Development
Table 46. Celgene Company Detail
Table 47. Celgene Business Overview
Table 48. Celgene CAR T-Cell Immunotherapy Product
Table 49. Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 50. Celgene Recent Development
Table 51. Kite Pharma Company Detail
Table 52. Kite Pharma Business Overview
Table 53. Kite Pharma CAR T-Cell Immunotherapy Product
Table 54. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 55. Kite Pharma Recent Development
Table 56. Oxford BioMedica Company Detail
Table 57. Oxford BioMedica Business Overview
Table 58. Oxford BioMedica CAR T-Cell Immunotherapy Product
Table 59. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 60. Oxford BioMedica Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis CAR T-Cell Immunotherapy Product
Table 64. Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Gilead Company Detail
Table 67. Gilead Business Overview
Table 68. Gilead CAR T-Cell Immunotherapy Product
Table 69. Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 70. Gilead Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer CAR T-Cell Immunotherapy Product
Table 74. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Cellectis Company Detail
Table 77. Cellectis Business Overview
Table 78. Cellectis CAR T-Cell Immunotherapy Product
Table 79. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 80. Cellectis Recent Development
Table 81. Bellicum Company Detail
Table 82. Bellicum Business Overview
Table 83. Bellicum CAR T-Cell Immunotherapy Product
Table 84. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 85. Bellicum Recent Development
Table 86. Mustang Bio Company Detail
Table 87. Mustang Bio Business Overview
Table 88. Mustang Bio CAR T-Cell Immunotherapy Product
Table 89. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 90. Mustang Bio Recent Development
Table 91. CARsgen Therapeutics Company Detail
Table 92. CARsgen Therapeutics Business Overview
Table 93. CARsgen Therapeutics CAR T-Cell ImmunotherapyProduct
Table 94. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 95. CARsgen Therapeutics Recent Development
Table 96. Xyphos Company Detail
Table 97. Xyphos Business Overview
Table 98. Xyphos CAR T-Cell ImmunotherapyProduct
Table 99. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 100. Xyphos Recent Development
Table 101. Minerva Biotechnologies Company Detail
Table 102. Minerva Biotechnologies Business Overview
Table 103. Minerva Biotechnologies CAR T-Cell ImmunotherapyProduct
Table 104. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 105. Minerva Biotechnologies Recent Development
Table 106. Adaptimmune Company Detail
Table 107. Adaptimmune Business Overview
Table 108. Adaptimmune CAR T-Cell ImmunotherapyProduct
Table 109. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 110. Adaptimmune Recent Development
Table 111. Ziopharm Oncology Company Detail
Table 112. Ziopharm Oncology Business Overview
Table 113. Ziopharm Oncology CAR T-Cell ImmunotherapyProduct
Table 114. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 115. Ziopharm Oncology Recent Development
Table 116. Aurora Biopharma Company Detail
Table 117. Aurora Biopharma Business Overview
Table 118. Aurora Biopharma CAR T-Cell ImmunotherapyProduct
Table 119. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 120. Aurora Biopharma Recent Development
Table 121. Creative Biolabs Company Detail
Table 122. Creative Biolabs Business Overview
Table 123. Creative Biolabs CAR T-Cell ImmunotherapyProduct
Table 124. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
Table 125. Creative Biolabs Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2021 VS 2028
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application in 2021 & 2028
Figure 5. Hematologic Malignancies Case Studies
Figure 6. Solid Malignancies Case Studies
Figure 7. CAR T-Cell Immunotherapy Report Years Considered
Figure 8. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global CAR T-Cell Immunotherapy Market Share by Region: 2021 VS 2028
Figure 11. Global CAR T-Cell Immunotherapy Market Share by Players in 2021
Figure 12. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2021
Figure 14. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America CAR T-Cell Immunotherapy Market Share by Country (2017-2028)
Figure 16. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe CAR T-Cell Immunotherapy Market Share by Country (2017-2028)
Figure 20. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Region (2017-2028)
Figure 28. China CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America CAR T-Cell Immunotherapy Market Share by Country (2017-2028)
Figure 36. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Country (2017-2028)
Figure 40. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 43. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 44. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 45. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 46. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 47. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 49. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 50. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 51. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 52. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 53. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 54. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 55. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 56. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 57. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 58. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs